M
Mediktor
Digital & mobile health solutions based in artificial intelligence and machine learning techniques
About Mediktor
In 2011, Oscar García-Esquirol, an intensive care provider, and Cristian Pascual, an industrial engineer, founded Mediktor in Barcelona, Spain. Their vision was to revolutionize healthcare access through technology. Mediktor emerged as an AI-based medical assistant designed to perform triage and pre-diagnosis, offering users a preliminary assessment of their symptoms before consulting a healthcare professional.
Read full description
Mediktor's journey is marked by its commitment to clinical validation, ensuring that its AI system is not only advanced but also reliable. This dedication to accuracy and reliability has positioned Mediktor as a leader in digital health solutions. The company has successfully raised $15.8 million in funding, underscoring investor confidence in its innovative approach to healthcare.
As Mediktor continues to grow, it remains focused on enhancing its AI capabilities and expanding its reach. The company's story is a testament to the transformative power of technology in healthcare, providing a glimpse into a future where AI plays a crucial role in medical decision-making.
At a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Barcelona, Spain
- Employees
- 39
- Open positions
- 5
- Dealroom signal
- 61.1/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Telemedicine, Core AI, Virtual Assistant, Tech for Hospitals and Clinics, Clinical Decision Support, Tech for Medical Professionals
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning, Mobile app
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Jun 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Oct 2021 | $13M | $52M | Alta Life Sciences · MTIP | — |
| SERIES A✓Equity / VC | Dec 2018 | $3.4M | $14M | Castel Capital · NAOS · Alta Life Sciences | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Mediktor is 59K monthly website visits, up 436.4% over the last three months. Mediktor's team declined 26.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Alta Life Sciences- CCCastel Capital
NAOS
MTIP
Other known investors1 additional known investor
- PVPalladium Corporate Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mediktor on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mediktor’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.